Alpha-1 antitrypsin deficiency: The European experience

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 10, Issue S1, 2013, Pages 50-53

  Stockley, Robert A ^a   Dirksen, Asger ^b   Stolk, Jan ^c  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alpha 1 antitrypsin; Deficiency; Emphysema

Indexed keywords

ALPHA 1 ANTITRYPSIN DEFICIENCY; AWARENESS; COMPUTER ASSISTED TOMOGRAPHY; DENMARK; DENSITOMETRY; DISEASE REGISTRY; HEALTH CARE POLICY; LUNG FUNCTION; NEWBORN SCREENING; PREVALENCE; PRIORITY JOURNAL; REVIEW; SWEDEN; UNITED KINGDOM;

ALPHA 1-ANTITRYPSIN DEFICIENCY; EUROPE; HUMANS; REGISTRIES;

EID: 84875670108     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2013.765838     Document Type: Review

References (20)

1. Laurell C, Eriksson, S. The electrophorectic alpha-1 globulin pattern of serum in alpha 1-antitrypsin deficiency. Scand J Clin Lab Invest 1963; 15:132-140.
2. Fagerhol MK, Laurell CB. The polymorphism of prealbumins and alpha-1 antitrypsin in human sera. Clin Chim Acta 1967; 16(2):199-203.
3. Turino GM, Senior RM, Garg GD, Keller S, Levi MM, Mandl I. Serum elastase inhibitor deficiency and alpha-1 antitrypsin deficiency in patients with obstructive emphysema. Science 1969; 165:709-711.
4. Lomas DA, Evans DL, Finch JT. The mechanism of Z alpha-1 antitrypsin accumulation in the liver. Nature 1992; 357(6379):605-607.
5. The Alpha-1 Antitrypsin Deficiency Registry Study Group. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. Am J Respir Crit Care Med 1998; 158(1):49-59.
6. Seersholm N, et al. Does alpha-1 antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. Eur Respir J 1997; 10(10):2260-2263.
7. Wencker M, et al. Longitudinal follow-up of patients with alpha-1 protease inhibitor deficiency before and during therapy with IV alpha-1 protease inhibitor. Chest 2001; 119(3):737-744.
8. Chapman KR, et al. Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis. COPD 2009; 6(3):177-184.
9. Bernspang E, et al. CT lung densitometry in young adults with alpha-1 antitrypsin deficiency. Respir Med 2011; 105(1):74-79.
10. Tanash HA, et al. Survival in severe alpha-1 antitrypsin deficiency (PiZZ). Respir Res 2010; 11:44
11. Dawkins PA, et al. Rate of progression of lung function impairment in alpha-1 antitrypsin deficiency. Eur Respir J 2009; 33(6):1338-1344.
12. Dowson LJ, Guest PJ, Stockley RA. Longitudinal changes in physiological, radiological, and health status measurements in alpha-1 antitrypsin deficiency and factors associated with decline. Am J Respir Crit Care Med 2001; 164(10 Pt 1):1805- 1809.
13. Needham M, Stockley RA. Exacerbations in alpha-1 antitrypsin deficiency. Eur Respir J 2005; 25(6):992-1000.
14. Vijayasaratha K, Stockley RA. Reported and unreported exacerbations of COPD: Analysis by diary cards. Chest 2008; 133:34-41.
15. Parr DG, et al. Validation of computed tomographic lung densitometry for monitoring emphysema in alpha-1 antitrypsin deficiency. Thorax 2006; 61(6):485-490.
16. Dawkins PA, et al. Predictors of mortality in alpha-1 antitrypsin deficiency. Thorax 2003; 58(12):1020-1026.
17. Dirksen A, et al. A randomized clinical trial of alpha-1 antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999; 160 (5 Pt 1):1468-1472.
18. Dirksen A, et al. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1- antitrypsin deficiency. Eur Respir J 2009; 33(6):1345-1353.
19. World Health Organization Alpha-1 antitrypsin deficiency: memorandum from a WHO meeting, available on their web site. Bull World Health Organ 1997; 75(5):397-415.
20. Carter RI, et al. The fibrinogen cleavage product alpha-Val360, a specific marker of neutrophil elastase activity in vivo. Thorax 2011; 66(8):686-691.